Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 561Advanced Proteomics Techniques and ApplicationsMetabolomics and Mass Spectrometry StudiesBioinformatics and Genomic Networks

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.

Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions

Open access
Pan, Cuiping, Kumar, Chanchal, Bohl, Sebastian, Klingmueller, Ursula, Mann, Matthias·2009·Molecular & Cellular Proteomics

Abstract

Biological experiments are most often performed with immortalized cell lines because they are readily available and can be expanded without limitation. However, cell lines may differ from the in vivo situation in important aspects. Here we introduce a straightforward methodology to compare cell lines to their cognate primary cells and to derive a comparative functional phenotype. We used SILAC (stable isotope labeling by amino acids in cell culture) for quantitative, mass spectrometry-based comparison of the hepatoma cell line Hepa1-6 with primary hepatocytes. The resulting quantitative proteome of 4,063 proteins had an asymmetric distribution, with many proteins down-regulated in the cell line. Bioinformatic analysis of the quantitative proteomics phenotypes revealed that Hepa1-6 cells were deficient in mitochondria, reflecting re-arrangement of metabolic pathways, drastically up-regulate cell cycle-associated functions and largely shut down drug metabolizing enzymes characteristic for the liver. This quantitative knowledge of changes provides an important basis to adapt cell lines to more closely resemble physiological conditions.

Overview

CoChat Summary

TL;DR

This study uses SILAC-based quantitative proteomics to compare the mouse hepatoma cell line Hepa1–6 with primary hepatocytes, identifying and quantifying 4,063 proteins. It finds widespread proteome differences, including loss of liver-specific drug-metabolizing and mitochondrial functions and up-regulation of proliferation-associated functions, and proposes a method for comparative proteomic phenotyping.

Key findings

  • More than half of the quantified proteome changed at least 2-fold between primary hepatocytes and Hepa1–6, with many proteins down-regulated in the cell line and comparatively few up-regulated.
  • Liver-specific drug-metabolizing enzymes were largely lost in Hepa1–6: of 32 identified P450 proteins, 25 were down-regulated at least 10-fold; FMO, UGT, SULT, and GST families were also severely down-regulated.
  • Mitochondria were strongly over-represented in primary hepatocytes (p < 10−62); of 452 GO-annotated mitochondrial proteins, 67% were expressed several-fold lower in Hepa1–6, and oxidative phosphorylation, urea cycle, and steroid biosynthesis were enriched in primary cells.
  • Proliferation-related categories were up-regulated in Hepa1–6, including cell cycle (p < 10−9), DNA synthesis (p < 10−4), and RNA polymerase (p < 10−3); a high-glucose control experiment found 96% of proteins constant within 2-fold.

Methods

  • SILAC labeling of Hepa1–6 cells (light/heavy arginine and lysine for 8 passages, ~3 weeks) was compared with primary mouse hepatocytes isolated from two mice and processed separately after 14 h cultivation.
  • Proteins were digested, fractionated by OFFGEL, and analyzed by LC-MS/MS on LTQ-FT or LTQ-Orbitrap instruments; data were processed with MaxQuant and searched with Mascot against the IPI mouse database.
  • The quantified proteome was divided into five quantiles and analyzed by GO and KEGG enrichment followed by hierarchical clustering of p values; a separate SILAC experiment compared high glucose versus physiological glucose over 3 weeks.

Limitations

  • The paper states that only a specific time point of primary cells and a specific cell type were analyzed, and whether findings generalize to other primary cell preparations or cell types needs future establishment.
  • The paper notes that over-representation of some non-liver or non-animal categories reflects the still-evolving state of pathway database annotation rather than a limitation of the technology.
  • Evident from the text: the study compares one mouse hepatoma cell line with primary hepatocytes from two mice, and most protein changes were not independently validated except mitochondrial abundance by DAPI/Mitotracker staining.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1074/mcp.m800258-mcp200

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Strategy for comparing primary cells with immortalized cell lines. Primary hepatocytes were isolated and grown for 14 h. The Hepa1–6 cell line was completely SILAC-labeled with 13C615N4-arginine and 13C615N2-lysine. Cell extracts were combined and by online high-resolution MS on a linear ion trap Fourier transform instrument (LTQ-FT) or LTQ-Orbitrap. The bottom part of the figure exemplifies peptides from proteins mostly expressed in primary cells, equally expressed in both or mostly expressed in Hepa1–6.
Fig. 1. Strategy for comparing primary cells with immortalized cell lines. Primary hepatocytes were isolated and grown for 14 h. The Hepa1–6 cell line was completely SILAC-labeled with 13C615N4-arginine and 13C615N2-lysine. Cell extracts were combined and by online high-resolution MS on a linear ion trap Fourier transform instrument (LTQ-FT) or LTQ-Orbitrap. The bottom part of the figure exemplifies peptides from proteins mostly expressed in primary cells, equally expressed in both or mostly expressed in Hepa1–6.CC BY-NC · PubMed Central
Fig. 2. Fold-change distributions of the proteome. A, quantitative comparison of the primary against the Hepa1–6 cell line proteome. The distribution was divided into five quantiles as follows. High relative expression in primary cells (0–15%, at least 4-fold down-regulation), mostly expressed in primary cells (15–25%, −4 to −1.5-fold regulation), not highly regulated proteins (25–75%; −1.5 to +2.8), mostly expressed in Hepa1–6 (75–85; 2.8 to 3.6-fold), highly expressed in Hepa1–6 (85–100%, more than 3.6-fold change). Color coding of these categories is indicated at the top of the panel. B, biological replicate of the experiment showing excellent reproducibility (see also supplemental Fig. 2). C, quantitative comparison of the Hepa1–6 proteome cultured in high glucose (28 nm) and physiological glucose concentration (8 nm).
Fig. 2. Fold-change distributions of the proteome. A, quantitative comparison of the primary against the Hepa1–6 cell line proteome. The distribution was divided into five quantiles as follows. High relative expression in primary cells (0–15%, at least 4-fold down-regulation), mostly expressed in primary cells (15–25%, −4 to −1.5-fold regulation), not highly regulated proteins (25–75%; −1.5 to +2.8), mostly expressed in Hepa1–6 (75–85; 2.8 to 3.6-fold), highly expressed in Hepa1–6 (85–100%, more than 3.6-fold change). Color coding of these categories is indicated at the top of the panel. B, biological replicate of the experiment showing excellent reproducibility (see also supplemental Fig. 2). C, quantitative comparison of the Hepa1–6 proteome cultured in high glucose (28 nm) and physiological glucose concentration (8 nm).CC BY-NC · PubMed Central
Fig. 3. Functional phenotyping of the proteome. The quantiles resulting from quantitative proteome comparison in Fig. 2 were separately analyzed for enriched KEGG pathways and clustered for the z-transformed p values. The color bar on top represents the quantiles. Representative pathways enriched in the protein population of each quantile are annotated. For complete listing of significant categories see supplemental Fig. 3.
Fig. 3. Functional phenotyping of the proteome. The quantiles resulting from quantitative proteome comparison in Fig. 2 were separately analyzed for enriched KEGG pathways and clustered for the z-transformed p values. The color bar on top represents the quantiles. Representative pathways enriched in the protein population of each quantile are annotated. For complete listing of significant categories see supplemental Fig. 3.CC BY-NC · PubMed Central
Fig. 4. Phenotypic proteome comparison at the cellular component level. A, the quantiles resulting from quantitative proteome comparison in Fig. 2 were separately analyzed for enriched gene ontology cellular components and clustered for the z-transformed p values. The color bar on top represents the quantiles. Representative categories enriched in the protein population of each quantile are annotated. For complete listing of significant categories and p values, see supplemental Fig. 3. Prominent mitochondria-related categories for the primary cells are highlighted in red and prominent nucleus related categories in blue. B, nuclear (DAPI) and mitochondrial (Mitotracker) staining of primary hepatocytes and Hepa1–6 cells. Most primary hepatocytes are binuclear (34). Magnification factor is ×400. DAPI, 4′,6-diamidino-2-phenylindole.
Fig. 4. Phenotypic proteome comparison at the cellular component level. A, the quantiles resulting from quantitative proteome comparison in Fig. 2 were separately analyzed for enriched gene ontology cellular components and clustered for the z-transformed p values. The color bar on top represents the quantiles. Representative categories enriched in the protein population of each quantile are annotated. For complete listing of significant categories and p values, see supplemental Fig. 3. Prominent mitochondria-related categories for the primary cells are highlighted in red and prominent nucleus related categories in blue. B, nuclear (DAPI) and mitochondrial (Mitotracker) staining of primary hepatocytes and Hepa1–6 cells. Most primary hepatocytes are binuclear (34). Magnification factor is ×400. DAPI, 4′,6-diamidino-2-phenylindole.CC BY-NC · PubMed Central
Fig. 5. Phenotypic proteome comparison at the pathway level. A, mapping of protein ratios on the fatty acid metabolism pathway reveals that almost the entire module is down-regulated several-fold in Hepa1–6. Proteins are color-coded according to their relative expression in the two cell types according to the scheme in Fig. 2. B, KEGG pathway mapping of ErbB and PI3K signaling pathway shows that they are equally present in primary cells and the cell line. PI3K, phosphatidylinositol 3-kinase.
Fig. 5. Phenotypic proteome comparison at the pathway level. A, mapping of protein ratios on the fatty acid metabolism pathway reveals that almost the entire module is down-regulated several-fold in Hepa1–6. Proteins are color-coded according to their relative expression in the two cell types according to the scheme in Fig. 2. B, KEGG pathway mapping of ErbB and PI3K signaling pathway shows that they are equally present in primary cells and the cell line. PI3K, phosphatidylinositol 3-kinase.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 3 Not checked · 37 Own results and interpretations

22 more claims

Create a free account to see all 40 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Warburg, 1930, Ueber den Stoffwechsel der Tumoren, Biochemische Z., 152, 319

Cited by

See all 561

Metadata

Authors
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., & Mann, M.
Affiliations
  • Max Planck Institute of Biochemistry (DE)
  • Max Planck Society (DE)
Corresponding author
Mann, Matthias
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2009-03
Volume
8
Issue
3
Pages
443-450
ISSN
1535-9476 (ISSN-L)
OpenAlex
W2144754434
Cited by
561
References
37
Citations by year
2026: 30 · 2025: 33 · 2024: 32 · 2023: 30 · 2022: 33 · 2021: 49 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 42 · 2016: 27 · 2015: 21 · 2014: 28 · 2013: 32 · 2012: 21
FWCI
7.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular & Cellular Proteomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
Funders
European Commission
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
primary hepatocytes, mitochondrial dysfunction, drug-metabolizing enzymes
MeSH terms
Animals, Cell Line, Cells, Cultured, Organ Specificity, Phenotype, Proteome, Hepatocytes, Proteomics, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions. https://app.cochat.ai/papers/10.1074/mcp.m800258-mcp200
The paper
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., & Mann, M. (2009). Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.m800258-mcp200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.